IL-1β/CXCL12 signalling orchestrates adipocyte-pancreatic neuroendocrine tumor crosstalk. [PDF]
Oldani M +9 more
europepmc +1 more source
Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab. [PDF]
Netea SA +6 more
europepmc +1 more source
Integrative Computational Prediction Strategy for Antibody-Antigen Binding: A Case Study on Interleukin-1 Beta. [PDF]
Aygen ME, Uyar A.
europepmc +1 more source
Cross-national biologic treatment guidelines for FMF: a comparative analysis. [PDF]
Kasap Cuceoglu M +18 more
europepmc +1 more source
Marked regression of calcinosis with canakinumab in hyperphosphatemic familial tumoral calcinosis. [PDF]
Dauchez A +7 more
europepmc +1 more source
Safety and Effectiveness of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan: A Post-Marketing Surveillance Study. [PDF]
Akita F, Seko N, Yoneda T.
europepmc +1 more source
Evaluation of the Effect of IL-1 Antagonists on Pituitary Function. [PDF]
Aktas Koc F, Sariakcali B, Sahin A.
europepmc +1 more source
Idiopathic recurrent pericarditis in children: a tertiary care cohort highlighting the emergence and effectiveness of interleukin-1 blockade. [PDF]
Gunalp A +14 more
europepmc +1 more source
Difficult-to-Treat Rheumatoid Arthritis With Concomitant Yao Syndrome With Response to Dual-Inhibitor Therapy. [PDF]
Aljundi N, Piranavan P.
europepmc +1 more source
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study. [PDF]
Eviatar T +35 more
europepmc +1 more source

